Differential (Click to cross reference) adverse drug reaction arthralgia atypical autoantibodies autoimmune disease cancer associated myopathy carcinoma carcinoma of lung cardiotoxicity chemotherapy, CNS treatment and complications with chorea complications cranial nerve palsies creatine phosphokinase(CPK)elevated dropped head syndrome drug induced neurologic disorders duvalumab efficacy electroencephalogram, abnormalities of electromyogram encephalitis encephalitis, autoimmune extralimbic encephalitis facial nerve palsy gammaglobulin therapy, intravenous glutamic acid decarboxylase, antibody Guillain Barre syndrome hallucination hallucination, visual hemiplegia, progressive Hodgkin's disease iatrogenic neurologic disorders immune checkpoint inhibitors immune-related adverse events immunologic disease immunosuppression immunosuppressive agents immunotherapy ipilimumab limb-girdle weakness limbic encephalitis lymphoma melanoma, malignant mental status, abnormal mesial temporal lobe misdiagnosis monoclonal antibodies MRI, abnormal MRI, diffusion weighted MRI, FLAIR MRI, optic nerve muscle biopsy muscle pain muscle weakness muscle weakness, proximal myasthenia gravis myasthenia gravis, drug induced myocarditis myopathy myopathy, inflammatory myopathy, necrotizing myopathy, necrotizing, immune-mediated myositis nausea and vomiting neoplasm, metastatic neoplasm, metastatic to CNS neoplasm, metastatic to CNS-treatment of neurologic complications of, systemic cancer neurologic disease neurologic disease, diagnoses of neuromuscular junction neuromuscular junction, abnormality of neuroophthalmology neuropathy neuropathy, iatrogenic neurotoxic nivolumab ocular motility, disorders of ophthalmoplegia optic disc edema optic nerve, enhancement optic neuritis paresthesias pembrolizumab plasmapheresis precipitating factors prognosis progressive multifocal leucoencephalopathy progressive neurologic disorder ptosis respiratory failure review article rhabdomyolysis safety seizure steroid steroid therapy, CNS treatment and complications with systemic illness temporal lobe, lesion temporal lobe, lesion, bilateral treatment of neurologic disorder viral infection, CNS visual acuity, decreased visual loss weakness workup

Showing articles 0 to 11 of 11 A 48-Year-Old Woman with 6 Months of Vivid Visual Hallucinations Neurol 99:166-171, Kizza, J.,et al, 2022 Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors Neurol 97:e191-e202, Nersesjan, V.,et al, 2021 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma Case Rep Neurol Med 2018;doi:10.1155/2018/2548528, Shah, S.,et al, 2018 Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab Emerg Inf Dis 24:1594-1596, Martinot, M.,et al, 2018 Acute demyelinating polyneuropathy induced by nivolumab JNNP 89:435-437, Fukumoto, Y.,et al, 2018 Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain NEJM 379:722-730,789, Tawbi, H.A.,et al, 2018 Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer Neurol 91:e985-e994, Touat, M.,et al, 2018 Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016 Acute Demyelinating Polyneuropathy Caused by Nivolumab in a Man with Metastatic Non-Small Cell Lung Cancer J Gerontol Geriatr Res 5:3, Sabeeh-Ur-Rehman, B. & Bhaumik, S., 2016 Showing articles 0 to 11 of 11